Janssen trials ultrasound-guided approach to treating Crohn'...

In the highly competitive market for inflammatory diseases such as Crohn's, pharma companies are looking for ways to maximise benefits of already approved drugs, as well as

Takeda invests in patient-centric data firm Seqster

2019: the year of the pharma mega-merger

2019 will be remembered as the year of the pharma mega-merger. Richard Staines looks back at a year that changed the landscape of big pharma

Takeda sets sights on first-line lung cancer market with new...

Experts concerned over mixed results from Takeda's dengue va...

Takeda’s dengue vaccine has met its target of protection against the disease in children – but there are already concerns about mixed results among different strains of the potentially dead

Takeda nets $660m from product selloff to Germany’s Stada